James River Group (JRVR 1.47%), a specialty insurance provider focused on Excess & Surplus (E&S) lines and Specialty Admitted insurance, released its second quarter 2025 results on August 4, 2025. The company's Non-GAAP earnings per share were in line with analyst expectations at $0.23. However, GAAP revenue of $152.6 million was just below the $153.65 million consensus estimate. While the quarter was notable for record new business in its core E&S segment, overall profit metrics declined, and lower perform ...